EU says US stand on patent virus waiver is no 'magic bullet'

European Union leaders cranked up their criticism of the U.S. call to waive COVID-19 vaccine patents Saturday, arguing the move would yield no short-term or intermediate improvement in vaccine supplies and could even have a negative impact.